498 related articles for article (PubMed ID: 27431051)
21. Magnetic hyperthermia and pH-responsive effective drug delivery to the sub-cellular level of human breast cancer cells by modified CoFe
Oh Y; Moorthy MS; Manivasagan P; Bharathiraja S; Oh J
Biochimie; 2017 Feb; 133():7-19. PubMed ID: 27916642
[TBL] [Abstract][Full Text] [Related]
22. MRI of High-Glucose Metabolism Tumors: a Study in Cells and Mice with 2-DG-Modified Superparamagnetic Iron Oxide Nanoparticles.
Shan XH; Wang P; Xiong F; Gu N; Hu H; Qian W; Lu HY; Fan Y
Mol Imaging Biol; 2016 Feb; 18(1):24-33. PubMed ID: 26150194
[TBL] [Abstract][Full Text] [Related]
23. Iron oxide nanoparticles cause surface coating- and core chemistry-dependent endothelial cell ferroptosis.
Zhang X; Kong F; Wang T; Huang X; Li W; Zhang M; Wen T; Liu J; Zhang Y; Meng J; Xu H
Nanotoxicology; 2022; 16(9-10):829-843. PubMed ID: 36660964
[TBL] [Abstract][Full Text] [Related]
24. Preparation, characterization of 2-deoxy-D-glucose functionalized dimercaptosuccinic acid-coated maghemite nanoparticles for targeting tumor cells.
Xiong F; Zhu ZY; Xiong C; Hua XQ; Shan XH; Zhang Y; Gu N
Pharm Res; 2012 Apr; 29(4):1087-97. PubMed ID: 22173782
[TBL] [Abstract][Full Text] [Related]
25. Strategies to reduce the intracellular effects of iron oxide nanoparticle degradation.
Wu M; Gu L; Gong Q; Sun J; Ma Y; Wu H; Wang Y; Guo G; Li X; Zhu H
Nanomedicine (Lond); 2017 Mar; 12(5):555-570. PubMed ID: 28181458
[TBL] [Abstract][Full Text] [Related]
26. Dimercaptosuccinic acid-coated magnetite nanoparticles for magnetically guided in vivo delivery of interferon gamma for cancer immunotherapy.
Mejías R; Pérez-Yagüe S; Gutiérrez L; Cabrera LI; Spada R; Acedo P; Serna CJ; Lázaro FJ; Villanueva A; Morales Mdel P; Barber DF
Biomaterials; 2011 Apr; 32(11):2938-52. PubMed ID: 21277630
[TBL] [Abstract][Full Text] [Related]
27. Fates of Fe3O4 and Fe3O4@SiO2 nanoparticles in human mesenchymal stem cells assessed by synchrotron radiation-based techniques.
Tian F; Chen G; Yi P; Zhang J; Li A; Zhang J; Zheng L; Deng Z; Shi Q; Peng R; Wang Q
Biomaterials; 2014 Aug; 35(24):6412-21. PubMed ID: 24814428
[TBL] [Abstract][Full Text] [Related]
28. 2, 3-dimercaptosuccinic acid-modified iron oxide clusters for magnetic resonance imaging.
Xiong F; Yan C; Tian J; Geng K; Zhu Z; Song L; Zhang Y; Mulvale M; Gu N
J Pharm Sci; 2014 Dec; 103(12):4030-4037. PubMed ID: 25335461
[TBL] [Abstract][Full Text] [Related]
29. Superparamagnetic iron oxide nanoparticles for direct labeling of stem cells and in vivo MRI tracking.
Kim SJ; Lewis B; Steiner MS; Bissa UV; Dose C; Frank JA
Contrast Media Mol Imaging; 2016; 11(1):55-64. PubMed ID: 26234504
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal stromal cell labeling by new uncoated superparamagnetic maghemite nanoparticles in comparison with commercial Resovist--an initial in vitro study.
Skopalik J; Polakova K; Havrdova M; Justan I; Magro M; Milde D; Knopfova L; Smarda J; Polakova H; Gabrielova E; Vianello F; Michalek J; Zboril R
Int J Nanomedicine; 2014; 9():5355-72. PubMed ID: 25484583
[TBL] [Abstract][Full Text] [Related]
31. Uptake of dimercaptosuccinate-coated magnetic iron oxide nanoparticles by cultured brain astrocytes.
Geppert M; Hohnholt MC; Thiel K; Nürnberger S; Grunwald I; Rezwan K; Dringen R
Nanotechnology; 2011 Apr; 22(14):145101. PubMed ID: 21346306
[TBL] [Abstract][Full Text] [Related]
32. Amine-surface-modified superparamagnetic iron oxide nanoparticles interfere with differentiation of human mesenchymal stem cells.
Chang YK; Liu YP; Ho JH; Hsu SC; Lee OK
J Orthop Res; 2012 Sep; 30(9):1499-506. PubMed ID: 22337660
[TBL] [Abstract][Full Text] [Related]
33. Characterization of interaction of magnetic nanoparticles with breast cancer cells.
Calero M; Chiappi M; Lazaro-Carrillo A; Rodríguez MJ; Chichón FJ; Crosbie-Staunton K; Prina-Mello A; Volkov Y; Villanueva A; Carrascosa JL
J Nanobiotechnology; 2015 Feb; 13():16. PubMed ID: 25880445
[TBL] [Abstract][Full Text] [Related]
34. Biocompatibility and proteomic profiling of DMSA-coated iron nanocubes in a human glioblastoma cell line.
Ulanova M; Gloag L; Kim CK; Bongers A; Kim Duong HT; Gooding JJ; Tilley RD; Sachdev PS; Braidy N
Nanomedicine (Lond); 2024 Feb; 19(4):303-323. PubMed ID: 38270934
[TBL] [Abstract][Full Text] [Related]
35. In vivo MRI tracking of iron oxide nanoparticle-labeled human mesenchymal stem cells in limb ischemia.
Li XX; Li KA; Qin JB; Ye KC; Yang XR; Li WM; Xie QS; Jiang ME; Zhang GX; Lu XW
Int J Nanomedicine; 2013; 8():1063-73. PubMed ID: 23515426
[TBL] [Abstract][Full Text] [Related]
36. The effect of magnetic nanoparticles on neuronal differentiation of induced pluripotent stem cell-derived neural precursors.
Jiráková K; Šeneklová M; Jirák D; Turnovcová K; Vosmanská M; Babič M; Horák D; Veverka P; Jendelová P
Int J Nanomedicine; 2016; 11():6267-6281. PubMed ID: 27920532
[TBL] [Abstract][Full Text] [Related]
37. Tracing type 1 diabetic Tibet miniature pig's bone marrow mesenchymal stem cells in vitro by magnetic resonance imaging (1).
Tang KX; Yan JH; Shen YF; Li BY; Chen YM; Liu DY; Ma DD; Li J; Liang H; Weng JP
J Diabetes; 2014 Mar; 6(2):123-31. PubMed ID: 23962175
[TBL] [Abstract][Full Text] [Related]
38. Poly(N,N-dimethylacrylamide)-coated maghemite nanoparticles for stem cell labeling.
Babic M; Horák D; Jendelová P; Glogarová K; Herynek V; Trchova M; Likavanová K; Lesný P; Pollert E; Hájek M; Syková E
Bioconjug Chem; 2009 Feb; 20(2):283-94. PubMed ID: 19238690
[TBL] [Abstract][Full Text] [Related]
39. Effects of DMSA-coated Fe3O4 magnetic nanoparticles on global gene expression of mouse macrophage RAW264.7 cells.
Liu Y; Chen Z; Gu N; Wang J
Toxicol Lett; 2011 Aug; 205(2):130-9. PubMed ID: 21641980
[TBL] [Abstract][Full Text] [Related]
40. Formulation and in vitro evaluation of magnetoliposomes as a potential nanotool in colorectal cancer therapy.
Lorente C; Cabeza L; Clares B; Ortiz R; Halbaut L; Delgado ÁV; Perazzoli G; Prados J; Arias JL; Melguizo C
Colloids Surf B Biointerfaces; 2018 Nov; 171():553-565. PubMed ID: 30096477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
